反応式
[Cl:1][C:2]1[N:10]=[C:9]2[C:5]([NH:6][CH:7]=[N:8]2)=[C:4](Cl)[N:3]=1.[Cl:12][C:13]1[C:21]([Cl:22])=[CH:20][C:16]2[N:17]=[CH:18][NH:19][C:15]=2[CH:14]=1>C(O)CCC>[Cl:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[CH:7][NH:8]2)=[C:4]([N:17]2[C:16]3[CH:20]=[C:21]([Cl:22])[C:13]([Cl:12])=[CH:14][C:15]=3[N:19]=[CH:18]2)[N:3]=1参加物
4
実験手順
567 mg of 2,6-dichloropurine, 6 ml of butanol and 617 mg of 5,6-dichlorobenzimidazole are mixed and brought to a temperature of 100° C. for approximately 24 hours. The mixture is allowed to return to ambient temperature. Partial drying, washing with isopropanol and drying under vacuum at 50° C. are carried out, and 548 mg of expected product are obtained, in the form of gray/black-colored crystals.
後処理
- customto return to ambient temperature
- customPartial drying
- washwashing with isopropanol
- customdrying under vacuum at 50° C.
出典と根拠
- ORDレコード
- ord-76e0f40d11ff49809c50455260d74855
- 出典データセット
- uspto-grants-2009_01
- 特許番号
- US07476670B2
関連ノート
読み込み中…